Seer to Participate in the TD Cowen 45th Annual Health Care Conference

Core Insights - Seer, Inc. is participating in the TD Cowen 45th Annual Healthcare Conference in Boston, MA, highlighting its position in the life sciences sector [1] - The company will engage in a fireside chat on March 4, 2025, providing an opportunity for investors to gain insights into its operations and future plans [2] Company Overview - Seer is a life sciences company focused on developing transformative products for proteomics, specifically through its Proteograph™ Product Suite [3] - The Proteograph Product Suite includes engineered nanoparticles, consumables, automation instrumentation, and software designed for deep, unbiased proteomic analysis at scale [3] - The workflow is designed to be efficient and user-friendly, allowing integration into various laboratory settings, although it is intended for research use only and not for diagnostic procedures [3]